# Cardiovascular-Renal Adverse Prognosis Assessment System for Coronary Heart Disease With Chronic Kidney Disease Based on Metabolomics

> **NCT06383208** · — · RECRUITING · sponsor: **China-Japan Friendship Hospital** · enrollment: 470 (estimated)

## Conditions studied

- Chronic Kidney Diseases
- Coronary Heart Disease
- Lipid Metabolism Disorders

## Interventions

- **DIAGNOSTIC_TEST:** lipid metabolomics

## Key facts

- **NCT ID:** NCT06383208
- **Lead sponsor:** China-Japan Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 470 (ESTIMATED)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06383208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06383208, "Cardiovascular-Renal Adverse Prognosis Assessment System for Coronary Heart Disease With Chronic Kidney Disease Based on Metabolomics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06383208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*